Omniscient has developed a dual-view endoscope for conducting colonoscopies that could detect pre-cancerous growths currently missed by front-facing devices.
University of Arizona has spun out a new US-based colonoscopy device developer called Omniscient with an undisclosed amount of capital from its Tech Launch Arizona (TLA) tech transfer office.
Omniscient received the money across two rounds from TLA’s Asset Development Program, whose remit includes inventions not yet able to attract external investors.
The spinout will commercialise a dual-view endoscope for detecting indications of colon cancer internally with greater efficiency than conventional single-view models.
The endoscope delivers front-facing and 360 degree…
